Intensity of care and withdrawal of life-sustaining therapies in severe traumatic brain injury patients: a post-hoc analysis of a multicentre retrospective cohort study
Alexis F. Turgeon(Université Laval), Xavier Neveu(Université Laval), Michèle Shemilt(The Quebec Population Health Research Network), François Lauzier(Victim Support), Karen E. A. Burns(St. Michael's Hospital), Ryan Zarychanski(CancerCare Manitoba), Lynne Moore, Damon C. Scales(Health Sciences Centre), David Zygun(Alberta Health Services), Caroline Léger(University of Calgary), Françis Bernard(Hôpital du Sacré-Cœur de Montréal), Peter Gerges(Université Laval)
Cited by 13
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589
Age of Transfused Blood in Critically Ill Adults
|New England Journal of Medicine|2015|559
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548